Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Bressac

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Pathologie-Biologie|April 25, 2006
[Identification and management of hereditary breast-ovarian cancers (2004 update)]F Eisinger, B Bressac, D Castaigne, et al.
British Journal of Cancer|June 23, 2000
P53 germline mutations in childhood cancers and cancer risk for carrier individualsA Chompret, L Brugières, M Ronsin, et al.
American Journal of Human Genetics|May 1, 1997
BRCA2 mutations in hereditary breast and ovarian cancer in FranceO M Serova-Sinilnikova, L Boutrand, D Stoppa-Lyonnet, et al.
Journal of Medical Genetics|June 7, 2005
Comprehensive analysis of CDKN2A (p16INK4A/p14ARF) and CDKN2B genes in 53 melanoma index cases considered to be at heightened risk of melanomaK Laud, C Marian, M F Avril, et al.
British Journal of Cancer|November 30, 2006
Mutations in BHD and TP53 genes, but not in HNF1beta gene, in a large series of sporadic chromophobe renal cell carcinomaS Gad, S H Lefèvre, S K Khoo, et al.
Cancer Research|December 15, 1993
Analysis of p53 antibodies in patients with various cancers define B-cell epitopes of human p53: distribution on primary structure and exposure on protein surfaceR Lubin, B Schlichtholz, D Bengoufa, et al.
Clinical Genetics|March 17, 2017
Reassessing the clinical spectrum associated with hereditary leiomyomatosis and renal cell carcinoma syndrome in French FH mutation carriersM Muller, S Ferlicot, M Guillaud-Bataille, et al.
Annales De Dermatologie Et De Venereologie|January 21, 2015
[Recommendations for genetic testing and management of individuals genetically at-risk of cutaneous melanoma]M-F Avril, P Bahadoran, O Cabaret, et al.
Breast Cancer Research and Treatment|August 27, 2013
Lack of referral for genetic counseling and testing in BRCA1/2 and Lynch syndromes: a nationwide study based on 240,134 consultations and 134,652 genetic testsP Pujol, D Stoppa Lyonnet, T Frebourg, et al.
Digestive Diseases and Sciences|October 31, 2022
The Frequency of Germline BRCA and Non-BRCA HR-Gene-Variants in a Cohort of Pancreatic Cancer PatientsM Baz, V Gondran-Teiller, B Bressac, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Pathologie-Biologie|April 25, 2006
[Identification and management of hereditary breast-ovarian cancers (2004 update)]F Eisinger, B Bressac, D Castaigne, et al.
British Journal of Cancer|June 23, 2000
P53 germline mutations in childhood cancers and cancer risk for carrier individualsA Chompret, L Brugières, M Ronsin, et al.
American Journal of Human Genetics|May 1, 1997
BRCA2 mutations in hereditary breast and ovarian cancer in FranceO M Serova-Sinilnikova, L Boutrand, D Stoppa-Lyonnet, et al.
Journal of Medical Genetics|June 7, 2005
Comprehensive analysis of CDKN2A (p16INK4A/p14ARF) and CDKN2B genes in 53 melanoma index cases considered to be at heightened risk of melanomaK Laud, C Marian, M F Avril, et al.
British Journal of Cancer|November 30, 2006
Mutations in BHD and TP53 genes, but not in HNF1beta gene, in a large series of sporadic chromophobe renal cell carcinomaS Gad, S H Lefèvre, S K Khoo, et al.
Cancer Research|December 15, 1993
Analysis of p53 antibodies in patients with various cancers define B-cell epitopes of human p53: distribution on primary structure and exposure on protein surfaceR Lubin, B Schlichtholz, D Bengoufa, et al.
Clinical Genetics|March 17, 2017
Reassessing the clinical spectrum associated with hereditary leiomyomatosis and renal cell carcinoma syndrome in French FH mutation carriersM Muller, S Ferlicot, M Guillaud-Bataille, et al.
Annales De Dermatologie Et De Venereologie|January 21, 2015
[Recommendations for genetic testing and management of individuals genetically at-risk of cutaneous melanoma]M-F Avril, P Bahadoran, O Cabaret, et al.
Breast Cancer Research and Treatment|August 27, 2013
Lack of referral for genetic counseling and testing in BRCA1/2 and Lynch syndromes: a nationwide study based on 240,134 consultations and 134,652 genetic testsP Pujol, D Stoppa Lyonnet, T Frebourg, et al.
Digestive Diseases and Sciences|October 31, 2022
The Frequency of Germline BRCA and Non-BRCA HR-Gene-Variants in a Cohort of Pancreatic Cancer PatientsM Baz, V Gondran-Teiller, B Bressac, et al.
Pageof 7